Purchases and Sales Made in Q3 2022 in I Teos Therapeutics, Inc. (ITOS)
This table provides information about the institutional ownership of I Teos Therapeutics, Inc. (ITOS) during Q3 2022. The information is specifically focused on institutions that hold shares of iTeos Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-16.4K- 2.93% |
$305K - $447K
|
543K
$4.47M
|
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-17.9KClosed |
$333K - $489K
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-24.2K- 12.96% |
$451K - $661K
|
163K
$1.34M
|
|
|
Nov 14, 2022
Q3 2022
|
Man Group PLC
London, X0 |
SELL
|
- |
-24.3K- 17.27% |
$453K - $663K
|
117K
$959K
|
|
|
Nov 14, 2022
Q3 2022
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-29.2K- 10.03% |
$543K - $795K
|
262K
$2.15M
|
|
|
Nov 02, 2022
Q3 2022
|
Los Angeles Capital Management LLC
|
SELL
|
- |
-37K- 29.62% |
$688K - $1.01M
|
87.8K
$723K
|
|
|
Nov 10, 2022
Q3 2022
|
Schroder Investment Management Group
London, X0 |
SELL
|
- |
-41.3K- 38.26% |
$768K - $1.12M
|
66.6K
$548K
|
|
|
Nov 10, 2022
Q3 2022
|
Candriam S.C.A.
|
SELL
|
- |
-48.1K- 6.11% |
$895K - $1.31M
|
740K
$6.09M
|
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-67.5K- 16.41% |
$1.25M - $1.84M
|
344K
$2.83M
|
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-67.5K- 16.41% |
$1.25M - $1.84M
|
344K
$2.83M
|
|
|
Nov 14, 2022
Q3 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-69K- 44.46% |
$1.28M - $1.88M
|
86.2K
$709K
|
|
|
Nov 14, 2022
Q3 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-69K- 44.46% |
$1.28M - $1.88M
|
86.2K
$709K
|
|
|
Nov 14, 2022
Q3 2022
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-84.2K- 18.92% |
$1.57M - $2.3M
|
361K
$2.97M
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-90.4K- 57.12% |
$1.68M - $2.46M
|
67.8K
$558K
|
|
|
Nov 14, 2022
Q3 2022
|
Bvf Inc
San Francisco, CA |
SELL
|
- |
-118K- 6.14% |
$2.2M - $3.23M
|
1.81M
$14.9M
|
|
|
Nov 14, 2022
Q3 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-129K- 56.34% |
$2.4M - $3.52M
|
100K
$824K
|
|
|
Oct 26, 2022
Q3 2022
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-203K- 74.63% |
$3.78M - $5.54M
|
69.1K
$569K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-219K- 20.83% |
$4.08M - $5.98M
|
834K
$6.86M
|
|
|
Nov 14, 2022
Q3 2022
|
Eco R1 Capital, LLC
San Francisco, CA |
SELL
|
- |
-240K- 85.54% |
$4.46M - $6.53M
|
40.5K
$333K
|
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-370K- 14.95% |
$6.89M - $10.1M
|
2.11M
$17.3M
|
|
|
Nov 15, 2022
Q3 2022
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-558K- 88.47% |
$10.4M - $15.2M
|
72.8K
$599K
|
|
|
Nov 14, 2022
Q3 2022
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-583K- 97.27% |
$10.9M - $15.9M
|
16.4K
$135K
|